Alejandro Martín García-Sancho

Instituto de Investigación Biomédica de A Coruña

Spain

Research Interests

Explore related searches

Professors in Spain Professors in Immunology Immunology professors in Spain

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (19)

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Collaborators (23)

Jesús Pérez‐Losada

SPAIN

View details

Sonia Castillo‐Lluva

SPAIN

View details

José Jalife

University of Michigan

UNITED STATES

View details

Purificación Galindo-Villardón

Universidad de Salamanca Facultad de Medicina

SPAIN

View details

Ana Patiño-García

Clinica Universidad de Navarra

SPAIN

View details

Carmen Patino-Alonso

Associate professor (Department of Statistics and Operations Research)

Universidad de Salamanca

SPAIN

View details

María Begoña García Cenador

Profesor

Universidad de Salamanca Facultad de Medicina

SPAIN

View details

Jian-Hua Mao

Adjunct Professor, Comparative Biochemistry Program

University of California, Berkeley

UNITED STATES

View details

Jose Tomas Navarro Ferrando

Associate Professor

University of Barcelona

SPAIN

View details

Carlos Prieto

Head of Bioinformatics

Universidad de Salamanca

SPAIN

View details

Juan Jesús Cruz Hernández

Emerutus Professor

Universidad de Salamanca

SPAIN

View details

Josep Castellvi

Universitat Autònoma de Barcelona

SPAIN

View details

Fermin Sanchez-Guijo

Full-Professor of Medicine (Catedrático de Medicina)

Universidad de Salamanca

SPAIN

View details

Anna Gonzalez-Neira

Head

Centro Nacional de Investigaciones Oncológicas

SPAIN

View details

Manuel Fuentes

SPAIN

View details

MARÍA CORTÉS RODRÍGUEZ

PROFESOR ASOCIADO

Universidad de Salamanca

SPAIN

View details

Jan Walewski

Head of the Dept., Director of the Institute

Narodowy Instytut Onkologii im Marii Skłodowskiej-Curie Państwowy Instytut Badawczy w Warszawie

POLAND

View details

Antonio Pérez-Martínez

La Paz University Hospital

SPAIN

View details

Roberto Corchado Cobos

SPAIN

View details

Silvana Novelli

SPAIN

View details

Miguel Martin

Universidad Complutense de Madrid

SPAIN

View details

ANNALISA CHIAPPELLA

Fondazione IRCCS Istituto Nazionale dei Tumori

ITALY

View details

Pedro L Sanchez

Universidad de Salamanca

SPAIN

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Alejandro Martín García-Sancho

Research Interests

Explore related searches

Contact this professor

Articles (19)

Phase 2 trial of the farnesyltransferase inhibitor tipifarnib for relapsed/refractory peripheral T-cell lymphoma

Cost-Effectiveness Analysis of Axicabtagene Ciloleucel vs. Standard of Care in Second-Line Treatment for Relapsed/Refractory Large B-Cell Lymphoma in Spain

Impact of the kinetics of circulating anti-CD19 CAR-T cells and their populations on the outcome of DLBCL patients

CD8+NKs as a potential biomarker of complete response and survival with lenalidomide plus R-GDP in the R2-GDP-GOTEL trial in recurrent/refractory diffuse large B cell lymphoma

Cost of Treating Cutaneous T-Cell Lymphoma in Spain: Analysis of MICADOS Study Data by Disease Stage

Liquid biopsy for molecular characterization of diffuse large B-cell lymphoma and early assessment of minimal residual disease

New therapies for relapsed or refractory aggressive B-cell lymphoma increase survival: Analysis from the RELINF registry of the GELTAMO group

Personalized monitoring of circulating tumor DNA with a specific signature of trackable mutations after chimeric antigen receptor T-cell therapy in follicular lymphoma patients

Intermediate Molecular Phenotypes to Identify Genetic Markers of Anthracycline-Induced Cardiotoxicity Risk

Accuracy and prognostic impact of FDG PET/CT and biopsy in bone marrow assessment of follicular lymphoma at diagnosis: A Nation-Wide cohort study

Phase 3 SELENE Study: Ibrutinib Plus BR/R-CHOP in Previously Treated Patients with Follicular or Marginal Zone Lymphoma

Lenalidomide in combination with R‐ESHAP in patients with relapsed or refractory diffuse large B‐cell lymphoma: A phase 2 study from GELTAMO

Peripheral T‐cell lymphoma with a T follicular‐helper phenotype: A different entity? Results of the Spanish Real‐T study

Pembrolizumab in Relapsed or Refractory Primary Mediastinal Large B-Cell Lymphoma: Final Analysis of KEYNOTE-170

Treatment of Relapsed or Refractory Diffuse Large B-Cell Lymphoma: New Approved Options

Allogeneic Hematopoietic Stem Cell Transplantation in Transformed Follicular Lymphoma (tFL): Results of a Retrospective Multicenter Study from GELTAMO/GETH-TC Spanish Groups

Allogeneic Stem Cell Transplantation in Mantle Cell Lymphoma; Insights into Its Potential Role in the Era of New Immunotherapeutic and Targeted Therapies: The GETH/GELTAMO Experience

Ibrutinib in Combination With Rituximab for Indolent Clinical Forms of Mantle Cell Lymphoma (IMCL-2015): A Multicenter, Open-Label, Single-Arm, Phase II Trial

Real-world evidence of brexucabtagene autoleucel for the treatment of relapsed or refractory mantle cell lymphoma.

Collaborators (23)

Jesús Pérez‐Losada

Sonia Castillo‐Lluva

José Jalife

Purificación Galindo-Villardón

Ana Patiño-García

Carmen Patino-Alonso

María Begoña García Cenador

Jian-Hua Mao

Jose Tomas Navarro Ferrando

Carlos Prieto

Juan Jesús Cruz Hernández

Josep Castellvi

Fermin Sanchez-Guijo

Anna Gonzalez-Neira

Manuel Fuentes

MARÍA CORTÉS RODRÍGUEZ

Jan Walewski

Antonio Pérez-Martínez

Roberto Corchado Cobos

Silvana Novelli

Miguel Martin

ANNALISA CHIAPPELLA

Pedro L Sanchez

Make your next move.